A new trading day began on Tuesday, with Nuvation Bio Inc (NYSE: NUVB) stock price down -3.53% from the previous day of trading, before settling in for the closing price of $3.68. NUVB’s price has ranged from $1.54 to $4.09 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -49.14% over the past five years. Meanwhile, its annual earnings per share averaged 69.07%. With a float of $231.51 million, this company’s outstanding shares have now reached $336.84 million.
Let’s look at the performance matrix of the company that is accounted for 220 employees.
Nuvation Bio Inc (NUVB) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Nuvation Bio Inc is 32.56%, while institutional ownership is 53.50%. The most recent insider transaction that took place on Jun 18 ’25, was worth 17,100. In this transaction CHIEF PEOPLE OFFICER of this company bought 10,000 shares at a rate of $1.71, taking the stock ownership to the 29,591 shares. Before that another transaction happened on Jun 17 ’25, when Company’s Chief Financial Officer bought 4,000 for $1.79, making the entire transaction worth $7,160. This insider now owns 9,902 shares in total.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.12 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 69.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.14% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Here are Nuvation Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 84.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.56 in one year’s time.
